Eli Lilly to buy cancer drug developer Scorpion Therapeutics for $2.5 billion

(Reuters) – Eli Lilly (NYSE:LLY) said on Monday it would acquire cancer therapy developer Scorpion Therapeutics for $2.5 billion in cash.

Source

Leave a Reply

Your email address will not be published. Required fields are marked *